Advertisement

Cellular and Molecular Life Sciences

, Volume 75, Issue 9, pp 1499–1507 | Cite as

Amyloid and the origin of life: self-replicating catalytic amyloids as prebiotic informational and protometabolic entities

  • Carl Peter J. Maury
Open Access
Visions and reflections

Abstract

A crucial stage in the origin of life was the emergence of the first molecular entity that was able to replicate, transmit information, and evolve on the early Earth. The amyloid world hypothesis posits that in the pre-RNA era, information processing was based on catalytic amyloids. The self-assembly of short peptides into β-sheet amyloid conformers leads to extraordinary structural stability and novel multifunctionality that cannot be achieved by the corresponding nonaggregated peptides. The new functions include self-replication, catalytic activities, and information transfer. The environmentally sensitive template-assisted replication cycles generate a variety of amyloid polymorphs on which evolutive forces can act, and the fibrillar assemblies can serve as scaffolds for the amyloids themselves and for ribonucleotides proteins and lipids. The role of amyloid in the putative transition process from an amyloid world to an amyloid–RNA–protein world is not limited to scaffolding and protection: the interactions between amyloid, RNA, and protein are both complex and cooperative, and the amyloid assemblages can function as protometabolic entities catalyzing the formation of simple metabolite precursors. The emergence of a pristine amyloid-based in-put sensitive, chiroselective, and error correcting information-processing system, and the evolvement of mutualistic networks were, arguably, of essential importance in the dynamic processes that led to increased complexity, organization, compartmentalization, and, eventually, the origin of life.

Keywords

Origin-of-life theory Amyloid world RNA world Prion Molecular evolution Primordial genetics 

Introduction

It is generally believed that life on Earth passed through an RNA-world era in which RNA or an RNA-like polymer performed both informational and catalytic functions [1, 2, 3, 4]. It is, however, unlikely that a functional ribonucleotide polymer could have existed under early Earth conditions [5, 6, 7]. The amyloid world hypothesis of the origin of life [8] posits that during that early period, about 4 billion years ago, peptide amyloids were the first molecular entities that were able to self-replicate, transmit information, and evolve. The model has gained momentum from recent empirical and theoretical studies clarifying the molecular mechanisms underlying amyloid formation, amyloid-related catalysis, and protein-encoded information processing. Here, I examine the model in light of recent advancements, develop the model further, and broaden the perspective to include an outline how a transition from a primitive β-sheet-based replicator world to a complex amyloid–ribonucleo-protein world might have occurred.

The amyloid replicator

Within the framework of origin-of-life research, the question of the mechanism of replication and information transfer is crucial. Given the stability and functionality problems connected with the RNA-world hypothesis [5, 6, 7, 9], the view that some other type of informational system probably preceded the RNA-based one has gained an increasing attention. According to the amyloid world hypothesis, the primordial information system was based on structurally stable catalytic and self-replicating β-sheet amyloid conformers [8, 10, 11]. The basis for the model is the conformational arrangement of the amyloid fold (Fig. 1). The cross-β sheet structure of amyloid, in addition to providing remarkable stability, can convey multifunctionality to peptides [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26]. Even very short peptides may express diverse catalytic, replicative, and informational properties when adopting the amyloid conformation. This is in contrast to native peptides, which are easily denatured under harsh conditions, and whose functionality requires longer peptide sequences, the synthesis of which, again, would require an existing metabolic apparatus. Thus, under early Earth conditions, the amyloid fold would, obviously, have provided a substantial advantage for the survival and propagation of prebiotic peptides.
Fig. 1

Schematic representation of the β-sheet structure of amyloid. a Section of a β-pleated sheet. The β-strands, which run perpendicular to the long axis of the fibril, are marked in green and interstrand hydrogen bonds in red. b Hydrogen-bonding pattern of two antiparallel β-strands. c Antiparallel bilayered β-sheet. d Parallel bilayered β-sheet. Typically, the repeating unit of the amyloid fibrils consists of two tightly packed layers of β-sheets with side chains within the bilayers forming a dry interdigitating zipper interface. The zippers differ in the organization of the β-strands within and between the β-sheets and in the stacking of the β-sheets enabling the formation of a diversity of structural variants. The cross β-structure gives rise to a characteristic X-ray diffraction pattern with a meridional reflection at 0.48 nm and an equatorial reflection at about 1.0 nm. These reflections correspond to the interstrand and intersheet spacings, respectively. The mature amyloid fibril is a highly ordered linear supramolecular structure forming long unbranched fibrils ranging from 5 to 12 nm in diameter. References are given in the text

Encrypting environmental information

Recent research has clarified many aspects of the molecular mechanisms underlying the amyloid-mediated information system. It has become evident that the coding element is the steric zipper structure of the amyloid motif and that recognition occurs by amino acid side chain complementarity [13, 18]. In the encryption process, environmental information is encoded in the three-dimensional structure of the amyloid conformer [27, 28]. The steric information can then be transferred to “daughter” molecular entities through the template-assisted conformational replication cycles generating replicas of the spatially altered amyloid conformer [11]. Fragmentation and the formation of new seeds characterize the primary replication process; the importance of fragment recycling in the prebiotic evolutive processes has been emphasized [29]. The oligomeric phase of the replication process appears to be essential for the inscription of environmental information.

A schematic representation of the replication cycles is shown in Fig. 2. Importantly, two different nucleation mechanisms exist. A primary one, that typically involves a short seed, and a secondary, fibril surface-catalyzed step, which occurs when a small, but critical amyloid concentration has been achieved [30, 31, 32, 33]. The fibril-catalyzed step is characterized by an initial fast docking phase followed by a slow structural rearrangement locking phase [34]. From a prebiotic perspective, the demonstrations of template-assisted ligation of fibrillogenic peptides from two shorter building blocks [23, 24, 25] and of amyloid-directed synthesis of its constituent peptides from amino acids [26] are important.
Fig. 2

Schematic representation of the amyloid model of the origin of life. The figure outlines the proposed pathway of one type of peptide monomer from a prebiotic mixture of various protopeptides. The nucleation-dependent replication system is in-put sensitive, chiroselective, and error correcting. An initial slow nucleation process is followed by a fast polymerization phase where peptide monomers are added the growing end of the protofilament. Fragmentation generates new seeds that can initiate repeated replication cycles. The same peptide monomer can give rise to different amyloid structures and molecular rearrangements are possible. Specific conformational changes can be replicated in the fibril/protofibril-catalyzed cycle II. Amyloid is also able to direct the synthesis of its own constituent peptides. The β-sheet conformers and ribonucleotides interact dynamically and cooperatively, and the amyloid-based supramolecular fibrillar assemblies can function as a primitive metabolic apparatus catalyzing the formation metabolite precursors. The model does not exclude the possibility an extraterrestrial origin of the primordial amino acids or a contribution of extraterrestrial amino acids to the terrestrial prebiotic amino acid pool. References are given in the text

Adaptive and enantioselective amyloids

A distinctive feature of amyloid formation is that the same peptide monomer can generate functionally and structurally different amyloid conformers of which one or several can propagate and make new copies of itself/themselves [35, 36]. This ability is important with respect to the evolvability of the system: evolution requires variation. The replicating system can adapt to even small changes in the external milieu. The environmentally induced fine-tuned changes in the amyloid architecture can then be replicated and the pool of the fittest variants can expand. In this model, the environmentally less suitable conformers are degraded and the released monomers/oligomers are reutilized in the replication cycles [11].

The amyloid polymorphs differ from each other in the architecture of the β-strands within and between the β-sheets and in the stacking of the β-plates, as well as in filament length. The number of protofilaments per fibril and the degree of twisting of the fibril can also vary. The β-sheets are tightly packed without water molecules between them; hydrogen bonds, van der Waals forces, and electrostatic polarization hold the zippers together [13, 18, 37]. Typically, amyloid is found as a homochiral structure which has been explained by a poorer spatial fit of heterochiral structures [38, 39]. The high enantioselectivity of the molecular recognition of β-sheets is likely to be relevant to the question of the origin of biological homochirality [40, 41]. In a prebiotic setting even a minute enantiomeric precursor imbalance [42, 43], if present, could be amplified in the template-directed chiroselective β-sheet self-replication cycles, explaining both the amplification and the chiral transmission steps of terrestrial homochirality.

Catalytic amyloids

The catalytic activity of the peptide-based β-sheet assemblies is an important aspect of the amyloid world model. Amyloids not only catalyze their own formation, but they are able to catalyze other chemical reactions too. Rufo et al. [16] showed that small, 7-residue amyloid-forming peptides form efficient catalysts of ester hydrolysis. Other studies have demonstrated amyloid-related aldolase [17, 19], ATP-ase [44], and carbonic anhydrase [22] activities, as well as copper-mediated oxygen activation [45]. The catalytic functions are fibril/protofibril-dependent: the corresponding nonaggregated peptides are catalytically inactive. Another feature is the metal dependence of several amyloid catalysts; metal ions both stabilize the fibrillar structure and shape ligand geometry. In a recent study, Lee et al. [46] determined the structure of a metalloamyloid esterase catalyst by solid-state NMR. The peptide formed parallel β-sheets that assembled into stacked bilayers with alternating hydrophobic and polar interphases. The hydrophobic interphase was stabilized by apolar side chains, whereas the polar interphase contained zinc-binding histidines. In another recent study, Omosun et al. [19] examined the catalytic activities of peptides assembling into well-defined amyloid nanotubes. They found that the density and proximity of the extended arrays of chiroselective catalytic sites accomplished template-assisted polymerization of new polymers. The depth of the co-linear cross-β grooves of a heptapeptide assembling in antiparallel in-register β-strands was shown to be important for the retro-aldol activity; the shallower grooves limited substrate binding and diminished catalytic activity. Though the total efficiency of the catalytic activities of the cross-β assemblies is, in most cases, only moderate and the catalytic repertoire limited, the amyloid supramolecular network can, in a way, be regarded as a primitive metabolic apparatus with protoenzymatic activities.

The prebiotic relevance of the β-sheet networks and assemblies was recently highlighted by Tena-Solsona et al. [17] who provided evidence for emergent catalytic behavior of self-assembled low-molecular-weight peptide aggregates, and by Nanda et al. [21] who demonstrated error correction within replication networks through the emergence of short polymers exhibiting selective autocatalytic properties. Very recently, Rout et al. [26] showed that an amyloid can direct the sequence-, regio-, and stereo-selective condensation of amino acid synthesis, and that the templating reaction is stable over a wide range of pH (5.6–8.6) and temperature (25–90 °C). This is of particular interest from the perspective of early molecular evolution as it demonstrates that an amyloid formed from short peptides can direct the synthesis of its own constituent peptides under plausible prebiotic Earth conditions.

Emergence of cooperative networks

The amyloid model fulfils key criteria of a valid origin-of-life theory, i.e., the requirements of replication, information transfer, and variation. By repeated replication cycles, the amyloid conformers can generate a variety of polymorphic fibrillar networks (Fig. 3) and structures such as nanotubes, nanospheres, and hydrogels [47]. The fibrillar assemblies can act as scaffolds for the amyloids themselves and for RNA, protein, and lipids [48, 49, 50, 51, 52, 53, 54, 55]. They could also, under harsh prebiotic conditions, provide protection for nucleobases and natively folded peptides/proteins. Notably, extant organisms utilize amyloid structures for protection against environmental hazards [56, 57, 58] and for driving compartment formation [59].
Fig. 3

Electron micrograph of a polymorphic fibrillar amyloid network self-assembled from a prebiotically relevant 9-mer peptide (EGGSVVAAD) in aqueous environment. Experimental conditions were as described in Ref. [10]

The role of amyloid in the putative transition of the pristine amyloid world to an amyloid–RNA–protein world is not limited to scaffolding and protection; the interactions of amyloid with ribonucleotides and protein are both cooperative and dynamic. Fibrillar amyloid can act as an auto-catalyzing surface [34, 60, 61, 62] and, in addition to promoting its own formation, can, in a similar manner to that of clay and other mineral surfaces [63, 64], bind nucleic acids and enhance their polymerization, which, in turn, can promote amyloid production [15, 65, 66, 67, 68]. Moreover, the amyloid–nucleic acid complexes may enhance nucleic acid hybridization [65]. With respect to compartmentalization and membrane formation, amyloid–lipid interactions are of key importance [50, 52, 55, 69, 70]. Amyloidogenesis is promoted by lipid interphases that lead to accelerated fibrillar network formation and the recruitment of both nucleic acids and lipids generating feed-back loops. The complex interactions between amyloids and ribonucleotides are also reflected in current biology: amyloid-forming proteins are overrepresented among the factors that modulate the transcription, translation, and storage of RNA [71], and amyloid-like aggregation has been implicated in the formation of both RNA granules [72] and P-bodies [73]. In certain instances, protein’s amyloidogenic properties and RNA-modulating activity are associated with the occurrence of glutamine/asparagine-rich sequence motifs.

The transition from an amyloid world to an amyloid–RNA–protein world is likely to have evolved over a long period of time. However, the amyloid model [8, 11, 74] is also compatible with a gradually coevolving RNA–protein world [75, 76]. The scaffolding properties, protection, and protocompartments provided by amyloid supramolecular structures in combination with the cooperative interactions and interdependence between amyloid, ribonucleotides, and protein are likely to have constituted a driving force in prebiotic molecular evolution.

The prion connection

Prions are self-propagating infectious protein-based agents that can cause severe neurodegenerative disease. The prion hypothesis postulates that a misfolded form of the prion protein is the causative and transmissible agent of prion disorders [77]. Most, if not all, of the extraordinary characteristics of prions, such as protease-resistance, thermal stability, transmissibility, and strain specificity, are closely related to the amyloid fold [12, 14, 35, 78, 79]. The conversion of the prion protein into the infectious form involves a conformational rearrangement of the protein that generates an amyloid structure, and the propagation of the prions occurs via a template-seeded replication mechanism very similar to that of amyloids in general [12, 78, 80]. In addition to disease-related prions, a number of functional prions that exploit the amyloid fold for evolutionarily selected biological processes have been identified [81]. These processes include polyamine regulation [82], signal transduction [83, 84], regulation of gametogenesis [85], hormone storage [86], epigenetic inheritance [87], and memory persistence [88].

The amyloidogenic regions of prions are evolutionarily conserved, and in many instances represented by short, low-complexity sequences enriched in glutamine/asparagine domains [89, 90]. Importantly, a marked homology exists between the amino acid sequences of peptides preferentially produced in the salt-induced peptide formation reaction simulating early Earth conditions and the sequences of known prions [91]. Extant prions, and their amyloid-based functional entities, may represent a relic of the pristine β-sheet-based information system, and the amyloid fold may represent the first functional protein fold [8, 74, 91, 92, 93].

Genetics before genetics

Information transfer on the early Earth for about 4000 million years ago occurred, according to the amyloid hypothesis, by means of a β-sheet peptide-based prion-like amyloid system in which environmentally derived information encrypted in the β-sheet zipper structure was transmitted by a templated conformational self-replication mechanism to “daughter” amyloid entities [8, 11, 74]. Recognition was mediated by amino acid side chain complementarity and coding by the β-sheet zipper structure [13, 18, 94]. The proposed system is characterized by both robustness and variability: the replication cycles are able to produce optimized stable molecular variants for evolutive forces to act on. From a primordial pool of random uncoded short protopeptides, the adaptive template-directed chiroselective and error correcting replication cycles generated amyloids that represented the first “coded” peptide polymers. Direct chemical interaction between amino acids/peptides and ribonucleotides in the primordial environment was probably important the evolution of the genetic code [95, 96].

The amyloid model emphasizes the importance of the cooperative interactions between amyloid and ribonucleotides and of the transition from a primitive β-sheet world to a more complex amyloid–RNA–protein world, a transition that was necessary from both an evolutionary and informational point of view: The information content of the β-sheet system, though potentially large, is very limited when compared to the virtually unlimited information content of a nucleic acid-based genetic system [13]. The β-system allows, on the other hand, for more rapid responses to environmental changes which would likely have been an advantage during early molecular evolution.

The amyloid hypothesis versus peptide/protein-first hypotheses

Though based on amino acids and peptides, there are fundamental differences between the amyloid world hypothesis [8, 11] and the peptide-/protein-/GADV-first hypotheses of the origin of life [97, 98, 99, 100]. The key point is conformation: the differences are based on the particular folding patterns of the molecular entities involved. The amyloid fold is structurally different from all the other protein folds and it is functionally unique. It has an extraordinarily stable molecular structure and conveys functionality even to short (e.g., 3- to 9-mer) peptides. This is in contrast to nonaggregated peptides that are likely to decompose under harsh conditions, and functionality requires longer peptide lengths. In a prebiotic setting, short functional (aggregated) peptides with a rigid structure would, obviously, have had a selective evolutionary advantage over less stable, natively folded longer peptides. Importantly, template-directed reactions in β-sheet-driven replication networks can perform error correction and lead to the enrichment of a functional polymer within prebiotically relevant mixtures [21].

Amyloid fibril formation by prebiotically relevant peptides

It is well documented that under conditions simulating early Earth conditions, amino acids and short peptides are readily formed [101, 102, 103, 104, 105]. A high content of hydrophobic amino acids and the presence of alternating hydrophobic and hydrophilic residues tend to increase the β-sheet forming potential of peptide mixtures [106, 107, 108, 109, 110, 111]. In a recent study, Greenwald et al. [112] specifically addressed the question of whether amyloid fibers can result from a condensation of amino acids under prebiotically plausible conditions. The study showed that fibrillar amyloid spontaneously formed under such conditions from a mixture of glycine, alanine, aspartate, and valine, all representing prebiotic “consensus” amino acids. An earlier study [10] had shown that a nonapeptide composed of six of the most abundantly produced amino acids in experiments simulating early Earth conditions [113], and also present in carbonaceous meteorites [114], generated polymorphic amyloid networks in an aqueous solution at temperatures likely to have existed on the primitive Earth. Moreover, intriguingly, a marked amino acid sequence homology has been observed between experimentally produced prebiotic peptides and extant amyloid-forming prions [91]. These findings are in line with the view that amyloids could have been formed and existed under early Earth conditions.

Toward life

A crucial stage in the origin of life was the emergence of the first informational molecular entity that was able to self-organize and evolve on the primordial Earth. The amyloid model, a hybrid replication-metabolism model of the origin of life, posits that, in the pre-RNA era, information storage and transfer was based on peptide-based catalytic amyloids. The template-assisted conformational replication cycles generate a variety of amyloid polymorphs on which evolutive forces can act. Amyloid, RNA, and protein interact dynamically and cooperatively, and the amyloid assemblages can function as primitive metabolic entities catalyzing the formation of simple metabolite precursors.

In conclusion, the emergence of an amyloid-based pristine in-put sensitive, chiroselective, and error correcting information-processing system, and the evolvement of mutualistic networks were, arguably, of essential importance in the dynamic processes that led to increased complexity, organization, compartmentalization, and, eventually, the origin of life.

Notes

Acknowledgements

I thank Fang Zhao for taking the electron micrograph in Fig. 3.

References

  1. 1.
    Gilbert W (1986) The RNA world. Nature 319:618CrossRefGoogle Scholar
  2. 2.
    Cech TR (1986) A model for the RNA-catalyzed reaction. Proc Natl Acad Sci USA 83:4360–4363PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Orgel LE (2004) Prebiotic chemistry and the origin of the RNA world. Crit Rev Biochem Mol Biol 39:99–123PubMedCrossRefGoogle Scholar
  4. 4.
    Higgs PG, Lehman N (2015) The RNA world. Molecular cooperation at the origin of life. Nat Rev Genet 16:7–17PubMedCrossRefGoogle Scholar
  5. 5.
    Yarus M (2011) Life from an RNA world: the ancestor within. Harvard University Press, Cambridge, pp 1–194. ISBN 978-0-674-06071-5Google Scholar
  6. 6.
    Robertson MP, Joyce GF (2012) The origins of the RNA world. Cold Spring Harb Perspect Biol.  https://doi.org/10.1101/cshperspect.a003608 PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Bernhardt HS (2012) The RNA world hypothesis: the worst theory of the early evolution of life (except for all the others). Biol Direct 7:23–37PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Maury CPJ (2009) Self-propagating β-sheet polypeptide structures as prebiotic informational molecular entities: the amyloid world. Orig Life Evol Biosph 39:141–150PubMedCrossRefGoogle Scholar
  9. 9.
    Ikehara K (2016) Evolutionary steps in the emergence of life deduced from the bottom-up approach and GADV hypothesis (top-down approach). Life 6:E6PubMedCrossRefGoogle Scholar
  10. 10.
    Maury CPJ, Liljeström M, Zhao F (2012) Was the first molecular replicator on the primitive Earth an informational amyloid? EGGSVVAAD, a prebiotically plausible peptide, spontaneously forms amyloid assemblies. J Biol Res 18:332–335Google Scholar
  11. 11.
    Maury CPJ (2015) Origin of life. Primordial genetics: information transfer in a pre-RNA world based on self-replicating beta-sheet amyloid conformers. J Theor Biol 382:292–297PubMedCrossRefGoogle Scholar
  12. 12.
    Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, Arnsdorf MF, Lindquist SL (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289:1317–1321PubMedCrossRefGoogle Scholar
  13. 13.
    Wiltzius JJW, Landau M, Nelson R, Sawaya MR, Apostol MI, Goldschmidt L, Soriaga AB, Cascio D, Rajashankar K, Eisenberg D (2009) Molecular mechanisms for protein-encoded inheritance. Nat Struct Mol Biol 16:973–978PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Wickner RB, Edskes HJ, Bateman DA, Kelly AC, Gorkowsky A, Dayani Y, Zhou A (2014) Amyloid-diseases of yeast: prions are proteins acting as genes. Essays Biochem 56:193–205PubMedCrossRefGoogle Scholar
  15. 15.
    Carny O, Gazit E (2011) Creating a prebiotic sanctuary: self assembling supramolecular peptide structures bind and stabilize RNA. Orig Life Evol Biosph 41:121–132PubMedCrossRefGoogle Scholar
  16. 16.
    Rufo CM, Moroz YS, Moroz OV, Stör J, Smith TA, Hu X, DeGrado WF, Korendovych IV (2014) Short peptides self-assemble to produce catalytic amyloids. Nat Chem 6:303–309PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Tena-Solsona M, Nanda J, Diaz-Oltra S, Chotera A, Ashkenasy G, Escuder B (2016) Emergent catalytic behavior of self-assembled low molecular weight peptide-based aggregates and hydrogels. Chem Eur J 22:6687–6694PubMedCrossRefGoogle Scholar
  18. 18.
    Riek R, Eisenberg DS (2016) The activities of amyloids from a structural perspective. Nature 539:227–235PubMedCrossRefGoogle Scholar
  19. 19.
    Omosun TO, Hsieh M-C, Childers WS, Das D, Mehta AK, Anthony NR, Pan T, Grover MA, Berland KM, Lynn DG (2017) Catalytic diversity in self-propagating peptide assemblies. Nat Chem 9:805–809PubMedCrossRefGoogle Scholar
  20. 20.
    Ivnitski D, Amit M, Rubinov B, Cohen-Luria R, Ashkenasy N, Ashkenasy G (2014) Introducing charge transfer functionality into prebiotically relevant peptide fibrils. Chem Commun (Camb) 50:6733–6736CrossRefGoogle Scholar
  21. 21.
    Nanda J, Rubinov B, Ivnitski D, Mukherjee R, Shtelman E, Motro Y, Miller Y, Wagner N, Cohen-Luria R, Ashkenasy G (2017) Emergence of native peptide sequences in prebiotic replication networks. Nat Commun 8:434PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Al-Garawi ZS, McIntosh BA, Neill-Hall D, Hatimy AA, Bagely MC, Serpell LC (2017) The amyloid architecture provides a scaffold fold for enzyme-like catalysis. Nanoscale 9:10773–10783PubMedCrossRefGoogle Scholar
  23. 23.
    Takahashi Y, Mihara H (2004) Construction of a chemically and conformationally self-replicating system of amyloid-like fibrils. Bioorg Med Chem 12:693–699PubMedCrossRefGoogle Scholar
  24. 24.
    Rubinov B, Wagner N, Rapaport H, Ashkenasy G (2009) Self-replicating amphiphilic beta-sheet peptides. Angew Chem Int Ed 48:6683–6686CrossRefGoogle Scholar
  25. 25.
    Bourbo V, Matmor M, Shtelman E, Rubinov B, Ashkenasy N, Ashkenasy G (2011) Self-assembly and self-replication of short amphiphilic beta-sheet peptides. Orig Life Evol Biosph 41:563–567PubMedCrossRefGoogle Scholar
  26. 26.
    Rout SK, Friedmann MP, Riek R, Greenwald J (2018) A prebiotic templated-directed peptide synthesis based on amyloids. Nat Commun 9:234–242PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Westergard L, True HL (2014) Extracellular environment modulates the formation and propagation of particular amyloid structures. Mol Microbiol 92:698–715PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Bhak G, Lee J, Kim TH, Lee S, Lee D, Palk SR (2014) Molecular inscription of environmental information into protein suprastructures: temperature effects on unit assembly of alfa-synuclein oligomers into polymorphic amyloid fibrils. Biochem J 464:259–269PubMedCrossRefGoogle Scholar
  29. 29.
    Valdya N, Walker SI, Lehman N (2013) Recycling of informational units leads to selection of replicators in a prebiotic soup. Chem Biol 20:241–252CrossRefGoogle Scholar
  30. 30.
    Jeong JS, Ansaloni A, Mezzenga R, Lashuel HA, Dietler G (2013) Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation. J Mol Biol 425:1765–1781PubMedCrossRefGoogle Scholar
  31. 31.
    Saric A, Chebaro YC, Knowles TP, Frenkel D (2014) Crucial role of nonspecific interactions in amyloid nucleation. Proc Natl Acad Sci USA 111:17869–17874PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Michaels TC, Lazell HW, Arosio P, Knowles TP (2015) Dynamics of protein aggregation and oligomer formation governed by secondary nucleation. J Chem Phys 143:054901PubMedCrossRefGoogle Scholar
  33. 33.
    Castello F, Paredes JM, Ruedas-Rama MJ, Martin M, Roldan M, Casares S, Orte A (2017) Two-step amyloid aggregation: sequential lag phase intermediates. Sci Rep 7:40065PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Schwierz N, Frost CV, Geissler PL, Zacharias M (2017) From Abeta filament to fibril: molecular mechanism of surface activated secondary nucleation from all-atom MD simulations. J Phys Chem B 121:671–682PubMedCrossRefGoogle Scholar
  35. 35.
    Tanaka M, Chien P, Naber M, Cooke R, Weissman JS (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428:323–328PubMedCrossRefGoogle Scholar
  36. 36.
    Tycko R (2014) Physical and structural basis for polymorphism in amyloid fibrils. Prot Sci 23:1528–1539CrossRefGoogle Scholar
  37. 37.
    Park J, Kahng B, Uwang W (2009) Thermodynamic selection of steric zipper pattern of the amyloid cross-beta spine. PLoS Comput Biol 5:e1000492PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Chung DM, Nowick JS (2004) Enantioselective molecular recognition between β-sheets. J Am Chem Soc 126:3062–3063PubMedCrossRefGoogle Scholar
  39. 39.
    Wadai H, Yamaguchi K-I, Takahashi S, Kanno T, Kawai T, Naiki H, Goto Y (2005) Sterospecific amyloid-like fibril formation by a peptide fragment of beta-2-microglobulin. Biochemistry 44:157–164PubMedCrossRefGoogle Scholar
  40. 40.
    Weissbuch I, Illos RA, Bolbach G, Lahav M (2009) Racemic beta-sheets as templates of relevance to the origin of homochirality of peptides: lessons from crystal chemistry. Acc Chem Res 42:1128–1140PubMedCrossRefGoogle Scholar
  41. 41.
    Wagner N, Rubinov B, Ashkenasy G (2011) Beta-sheet-induced chirogenesis in polymerization of oligopeptides. Chem Phys Chem 12:2771–2780PubMedCrossRefGoogle Scholar
  42. 42.
    Bada JL (1995) Origins of homochirality. Nature 374:594–595PubMedCrossRefGoogle Scholar
  43. 43.
    Hein JE, Blackmond DG (2012) On the origin of single chirality of amino acids and sugars in biogenesis. Acc Chem Res 45:2045–2054PubMedCrossRefGoogle Scholar
  44. 44.
    Monasterio O, Nova E, Diaz-Espinoza R (2017) Development of a novel catalytic amyloid displaying a metal-dependent ATPase-like activity. Biochem Biophys Res Commun 482:1194–1200PubMedCrossRefGoogle Scholar
  45. 45.
    Sternisha A, Makhlynets O (2017) Catalytic amyloid fibrils that bind copper to activate oxygen. Methods Mol Biol 1596:59–68PubMedCrossRefGoogle Scholar
  46. 46.
    Lee M, Wang T, Makhlynets OV, Wu Y, Polizzi NF, Wu H, Gosavi PM, Stöhr J, Korendovych IV, DeGrtado WF, Hong M (2017) Zinc-binding structure of a catalytic amyloid from solid-state NMR. Proc Natl Acad Sci USA 114:6191–6196PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Hamley IW (2007) Peptide fibrillization. Angew Chem Int Ed Engl 46:8128–8147PubMedCrossRefGoogle Scholar
  48. 48.
    Kodama H, Matsumura S, Yamashita T, Mihara H (2004) Construction of a protein array on amyloid-like fibrils using co-assembly of designed peptides. Chem Commun 24:2876–2877CrossRefGoogle Scholar
  49. 49.
    Nandi PK, Nicole JC (2004) Nucleic acid and prion interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent. J Mol Biol 344:827–837PubMedCrossRefGoogle Scholar
  50. 50.
    Domanov YA, Kinnunen PK (2008) Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers. J Mol Biol 376:42–54PubMedCrossRefGoogle Scholar
  51. 51.
    Liu P, Ni R, Mehta AK, Childres WS, Lakdawala A, Pingali SW, Thyjagarajan P, Lynn DG (2008) Nucleobase-directed amyloid nanotube assembly. J Am Chem Soc 130:16867–16869PubMedCrossRefGoogle Scholar
  52. 52.
    Relini A, Cavalleri O, Rolandi R, Gliozzi A (2009) The two-fold aspect of the interplay of amyloidogenic proteins with lipid membranes. Chem Phys Lipids 158:1–9PubMedCrossRefGoogle Scholar
  53. 53.
    Silva JL, Cordeiro Y (2016) The “Jekyll and Hyde” actions of nucleic acids on the prion-like aggregation of proteins. J Biol Chem 291:15482–15490PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Silva JL, Lima LM, Foguel D, Cordeiro Y (2008) Intriguing nucleic acid-binding features of mammalian prion protein. Trends Biochem Sci 33:132–140PubMedCrossRefGoogle Scholar
  55. 55.
    Lindberg DJ, Wesen E, Björkeroth J, Esbjörner EK (2017) Lipid membranes catalyse the fibril formation of the amyloid-beta (1–42) peptide through lipid-fibril interactions that reinforce secondary pathways. Biochim Biophys Acta 1859:1921–1929PubMedCrossRefGoogle Scholar
  56. 56.
    Barnhart MM, Chapman MR (2006) Curli biogenesis and function. Annu Rev Microbiol 60:131–147PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Iconomidou VA, Hamodrakas SJ (2008) Natural protective amyloids. Curr Protein Pept Sci 9:291–309PubMedCrossRefGoogle Scholar
  58. 58.
    Tagialegna A, Lasa I, Valle J (2016) Amyloid structures as biofilm matrix scaffolds. J Bacteriol 198:2579–2588CrossRefGoogle Scholar
  59. 59.
    Boke E, Ruer M, Wuhr M, Coughlin M, Lemaltre R, Gygi SP, Alberti SS, Drechsel D, Hyman AA, Mitchison TJ (2016) Amyloid-like self-assembly of a cellular compartment. Cell 166:637–650PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Kellermayer MS, Karsai A, Benke M, Soos K, Penke B (2008) Stepwise dynamics of epitaxially growing single amyloid fibrils. Proc Natl Acad Sci USA 105:141–144PubMedCrossRefGoogle Scholar
  61. 61.
    Hammarström P, Ali MM, Mishra R, Salagic B, Svensson S, Tengvall P, Lundström I (2011) An auto-catalytic surface for conformational replication of amyloid fibrils-genesis of an amyloid world? Orig Life Evol Biosph 41:373–383PubMedCrossRefGoogle Scholar
  62. 62.
    Rubio MA, Schlamadinger DE, White EM, Miranker AD (2014) Peptide amyloid surface display. Biochemistry 54:987–993PubMedCentralCrossRefGoogle Scholar
  63. 63.
    Joyce GF (2002) The antiquity of RNA-based evolution. Nature 418:214–221PubMedCrossRefGoogle Scholar
  64. 64.
    Huang W, Ferris JP (2006) One step, regio-selective synthesis of up to 50-mers RNA oligomers by montmorrionite catalysis. J Am Chem Soc 128:8914–8919PubMedCrossRefGoogle Scholar
  65. 65.
    Braun S, Humphreys C, Fraser E, Brancale A, Bochtler M, Dale TC (2011) Amyloid associated nucleic acid hybridization. PLoS One 6:e19125PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Liu C, Zhang Y (2011) Nucleic acid-mediated protein aggregation and assembly. Adv Protein Chem Struct Biol 84:1–40PubMedCrossRefGoogle Scholar
  67. 67.
    Alred EJ, Nguyen M, Martin M, Hansmann U (2017) Molecular dynamic simulations of early steps in RNA-mediated conversion of prions. Prot Sci 26:1524–1534CrossRefGoogle Scholar
  68. 68.
    Macedo B, Cordeiro Y (2017) Unraveling prion protein interactions with aptamers and other PrP-binding nucleic acids. Int J Mol Sci 18:1023PubMedCentralCrossRefGoogle Scholar
  69. 69.
    Mahalka AK, Maury CPJ, Kinnunen PK (2011) 1-palmoyl-2-(9′-oxononaoyl)-9-sn glycero-3-phosphocholine, an oxidized phospholipid, accelerates Finnish gelsolin amyloidosis in vitro. Biochemistry 50:4877–4889PubMedCrossRefGoogle Scholar
  70. 70.
    Deamer D (2017) The role of lipid membranes in life’s origin. Life 7:5PubMedCentralCrossRefGoogle Scholar
  71. 71.
    Nizhnikov AA, Antonets KS, Bondarev SA, Inge-Vechtomov SG, Derkatch IL (2016) Prions, amyloids, and RNA: pieces of a puzzle. Prion 10:182–206PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, Mirzaei H, Goldsmith EJ, Longgood J, Pei J, Grishin NV, Frantz DE, Schneider JW, Chen S, Li L, Sawaya MR, Eisenberg D, Tycko R, McKnight SL (2012) Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149:753–767PubMedCrossRefGoogle Scholar
  73. 73.
    Reijns MAM, Alexander RD, Spiller MP, Beggs JD (2008) A role for Q/N-rich aggregation-prone regions in P-body localization. J Cell Sci 121:2463–2472PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Maury CPJ (2008) Self-replicating protein conformations and information transfer: the adaptive β-sheet model. Biosci Hypotheses 1:82–89CrossRefGoogle Scholar
  75. 75.
    Caetano-Anolles G, Seufferheld MJ (2013) The coevolutionary roots of biochemistry and cellular organization challenge the RNA world paradigm. J Mol Microbiol Biotechnol 23:152–177PubMedCrossRefGoogle Scholar
  76. 76.
    Carter CW Jr (2015) What RNA world? Why a peptide/RNA partnership merits renewed experimental attention. Life 5:294–320PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363–13383PubMedCrossRefGoogle Scholar
  78. 78.
    Jones E, Surewicz WK (2005) Fibril conformation as the basis of species- and strain- dependent seeding specificity of mammalian prion amyloids. Cell 121:63–72PubMedCrossRefGoogle Scholar
  79. 79.
    Wickner RB, Shewmaker F, Edskes H, Kryndushkin D, Nemeecek J, McGlinchey R, Bateman D, Winchester CL (2010) Prion amyloid structure explains templating: how proteins can be genes. FEMS Yeast Res 10:980–991PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Collins SR, Douglas A, Vale RD, Weissman JS (2004) Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol 2:e321PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Maury CPJ (2009) The emerging concept of functional amyloid. J Int Med 265:329–334CrossRefGoogle Scholar
  82. 82.
    Namy O, Galopier A, Martini C, Matsufuij S, Fabret C, Roussel JP (2008) Epigenetic control of polyamines by the prion [PSI+]. Nat Cell Biol 10:1069–1075PubMedCrossRefGoogle Scholar
  83. 83.
    Li J, McQuade T, Siemer AB, Napetschinig J, Moriwaki K, Hsiao Y-S, Darnko E, Moquin D, Walz T, McDermott A, Ka-Ming Chan F, Wu H (2012) The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150:339–350PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Cai X, Chen J, Xu H, Jiang Q-X, Halfmann R, Chen ZJ (2014) Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156:1207–1222PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Berchowitz LE, Kabachinski G, Walker MR, Carlile TM, Gilbert WV, Schwartz TU, Amon A (2015) Regulated formation of an amyloid-like translational repressor governs gametogenesis. Cell 163:406–418PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KP, Simon R, Schubert D, Eisenberg D, Rivier J, Sawchenko P, Vale VV, Riek R (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325:328–332PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Shorter J, Lindquist S (2005) Prions as adaptive conduits of memory and inheritance. Nat Rev Genet 6:435–450PubMedCrossRefGoogle Scholar
  88. 88.
    Khan MR, Li L, Perez-Sanchez C, Saraf A, Florens L, Slaughter BD, Unruch JR, Si K (2015) Amyloidogenic oligomerization transforms Drosophila Orb2 from a translation repressor to an activator. Cell 163:1468–1483PubMedCrossRefGoogle Scholar
  89. 89.
    Michelitsch MD, Weissman JS (2000) A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc Natl Acad Sci USA 97:11910–11915PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Epinosa Angarica VP, Ventura S, Sancho J (2013) Discovering putative prion sequences in complete proteomes using probalistic representations of Q/N-rich domains. BMC Genomics 14:316CrossRefGoogle Scholar
  91. 91.
    Rode BM, Flader W, Sotriffer C, Righi A (1999) Are prions a relic of an early stage of peptide evolution. Peptides 20:1513–1516PubMedCrossRefGoogle Scholar
  92. 92.
    Chernoff YO (2004) Amyloidogenic domains, prions and structural inheritance: rudiments of early life or recent acquistion? Curr Opin Chem Biol 8:665–671PubMedCrossRefGoogle Scholar
  93. 93.
    Greenwald J, Riek R (2012) On the possible amyloid origin of protein folds. J Mol Biol 421:417–426PubMedCrossRefGoogle Scholar
  94. 94.
    Eisenberg DS, Sawaya MR (2017) Structural studies of amyloid proteins at the molecular level. Annu Rev Biochem 86:69–95PubMedCrossRefGoogle Scholar
  95. 95.
    Yarus M, Widmann JJ, Knight R (2009) RNA-amino acid binding: a stereochemical era for the genetic code. J Mol Evol 69:406–429PubMedCrossRefGoogle Scholar
  96. 96.
    Beier A, Zagrovic B, Polyansky A (2014) On the contribution of protein spatial organization to the physicochemical interconnection between proteins and their cognate mRNAs. Life 4:788–799PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Rode BM (1999) Peptides and the origin of life. Peptides 20:773–786PubMedCrossRefGoogle Scholar
  98. 98.
    Woolfson A (2000) Life without genes. Flamingo, London. ISBN 978-0006548744Google Scholar
  99. 99.
    Ikehara K (2005) Possible steps to the emergence of life: the GADV-protein world. Chem Res 5:107–118Google Scholar
  100. 100.
    Kurland CG (2010) The RNA dreamtime: modern cells feature proteins that might have supported a prebiotic peptide world, but nothing indicates that RNA world ever was. BioEssays 32:866–871PubMedCrossRefGoogle Scholar
  101. 101.
    Miller SL (1953) A production of amino acids under possible primitive earth conditions. Science 117:528–529PubMedCrossRefGoogle Scholar
  102. 102.
    Brack A (2007) From interstellar amino acids to prebiotic catalytic peptides: a review. Chem Biodivers 4:665–679PubMedCrossRefGoogle Scholar
  103. 103.
    Li F, Fitz D, Fraser DG, Rode BM (2008) Methionine peptide formation under primordial earth conditions. J Inorg Biochem 102:1212–1217PubMedCrossRefGoogle Scholar
  104. 104.
    Bada JL (2013) New insights into prebiotic chemistry from Stanley Miller’s spark discharge experiments. Chem Soc Rev 42:2186–2196PubMedCrossRefGoogle Scholar
  105. 105.
    Parker ET, Zhou M, Burton AS, Glavin DP, Dworkin JP, Krishnamurthy R, Fernandez FM, Bada JL (2014) A plausible simultaneous synthesis of amino acids and simple peptides on the primordial Earth. Angew Chem Int Ed Engl 53:8132–8136PubMedCrossRefGoogle Scholar
  106. 106.
    Brack A, Orgel LE (1975) Beta structures of alternating polypeptides and their possible prebiotic significance. Nature 256:383–387PubMedCrossRefGoogle Scholar
  107. 107.
    de la Chapelle A, Tolvanen R, Boysen G, SantavyJ Bleeker-Wagemaker L, Maury CPJ, Kere J (1992) Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 2:157–160PubMedCrossRefGoogle Scholar
  108. 108.
    Maury CPJ, Nurmiaho-Lassila E-L (1992) Creation of amyloid fibrils from mutant Asn-187 gelsolin peptides. Biochem Biophys Res Commun 183:227–231PubMedCrossRefGoogle Scholar
  109. 109.
    Maury CPJ, Nurmiaho-Lassila EL, Rossi H (1994) Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides. Lab Investig 70:558–564PubMedGoogle Scholar
  110. 110.
    West MW, Wang W, Patterson J, Mancias JD, Beasley JR, Hecht MH (1999) De novo amyloid proteins designed combinatorial libraries. Proc Natl Acad Sci USA 96:11211–11216PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Dyson HJ, Wright PE, Scheraga HA (2006) The role of hydrophobic interactions in the initiation and propagation of protein folding. Proc Natl Acad Sci USA 103:13057–13061PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Greenwald J, Friedmann MP, Riek R (2016) Amyloid aggregates arise from amino acid condensations under prebiotic conditions. Angew Chem Int Ed 55:11609–11613CrossRefGoogle Scholar
  113. 113.
    Van Gulik P, Massar S, Gilis D, Buhrman H, Rooman M (2009) The first peptides: the evolutionary transition between prebiotic amino acids and early proteins. J Theor Biol 261:531–539PubMedCrossRefGoogle Scholar
  114. 114.
    Botta O, Glavin DP, Kminek G, Bada JL (2002) Relative aminoacid concentrations as a signature for parent body processes in carbonaceous chondrites. Orig Life Evol Biosph 32:143–163PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.Department of MedicineUniversity of HelsinkiHelsinkiFinland

Personalised recommendations